Human ACAT2 activation kit by CRISPRa

CAT#: GA100031

ACAT2 CRISPRa kit - CRISPR gene activation of human acetyl-CoA acetyltransferase 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
ACAT2 mouse monoclonal antibody, clone OTI7B1 (formerly 7B1)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


ACAT2 (Myc-DDK-tagged)-Human acetyl-CoA acetyltransferase 2 (ACAT2)
    • 10 ug

CNY 3,656.00
CNY 3,990.00


ACAT2 mouse monoclonal antibody, clone OTI1B7 (formerly 1B7)
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ACAT2
Locus ID 39
Kit Components

GA100031G1, ACAT2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100031G2, ACAT2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100031G3, ACAT2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001303253, NM_005891
Summary The product of this gene is an enzyme involved in lipid metabolism, and it encodes cytosolic acetoacetyl-CoA thiolase. This gene shows complementary overlapping with the 3-prime region of the TCP1 gene in both mouse and human. These genes are encoded on opposite strands of DNA, as well as in opposite transcriptional orientation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2014]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...